bpc-157 fda approved 2025 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank bpc-157 fda status 2025 or

Exact BPC-157 Dosing Protocols (By Indication) What About Weight-Based Dosing

This spike in $NAD^+$ activates Sirtuin 1 (SIRT1) pathways, mimicking the cellular signaling patterns of intense calorie restriction and exercising muscle tissues without altering dietary intake

And it doesnt have to be intense

Skin is hyperextensible if it stretches greater than: 1.5 cm on the forearms 1.5 cm on the back of the hands 3 cm on the neck 3 cm on the knees Mild skin hyperextensibility may occur in people with any type of EDS

First, gastrointestinal distress: tirzepatide's most common side effects are nausea (up to 31% of patients in SURPASS trials), vomiting, diarrhea, and decreased appetite